OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/28/2025
Back to search
Official data from USPTO
MAMMATYPER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
02/28/2025
Trademark type
Combined
Nice classes
5, 10, 42, 44
Filing date
11/07/2022
Registration date
06/04/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/04/2024
Last transaction
02/28/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CN
Examiner
GILLES, DEBORAH
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
SHUWEN BIOTECH CO., LTD.
Representatives
Michael T. Smith Birch Stewart Kolasch & Birch LLP
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical purposes relating to obstetrics or breast cancer; chemical reagents for medical purposes relating to obstetrics or breast cancer; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; pharmaceutical drugs for the treatment of breast cancer; pharmaceutical preparations for the prevention and treatment of breast cancer; pharmaceutical products for the prevention and treatment of breast cancer; biological preparations for the treatment of breast cancer
Class 10
Testing apparatus for medical purposes relating to obstetrics and breast cancer for detecting cancer; genetic testing apparatus for medical purposes; diagnostic apparatus for medical purposes relating to obstetrics and breast cancer; apparatus for use in medical analysis relating to obstetrics or breast cancer for detecting cancer; medical apparatus and instruments relating to obstetrics and breast cancer; apparatus for DNA and RNA testing for medical purposesX-ray diagnostic apparatus
Class 42
Scientific research in the fields of obstetrics and breast cancer; scientific research on breast cancer for medical purposes; scientific research in the nature of conducting clinical trials for others in the fields of obstetrics and breast cancer; medical research in the fields of obstetrics and breast cancer; structural and functional analysis of genomes; research and development of pharmaceuticals of breast cancer; medical research in oncologybreast cancer; genetic testing for scientific research; technological research in the fields of obstetrics and breast cancer
Class 44
Genetic testing for medical use; genetic testing for medical purposes; telemedicine services on medical testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening relating to obstetrics and breast cancer; rental of medical equipmentequipment relating to obstetrics and breast cancer; medical therapy services in the fields of obstetrics and breast cancer; medical analysis services for the diagnosis of breast cancer; provide breast cancer screening services
Publications
History of USPTO decisions and trademark events.
31 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/12/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/07/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/16/2024
FIMP
FINAL DISPOSITION PROCESSED
11/16/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/04/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/04/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/19/2024
PUBO
PUBLISHED FOR OPPOSITION
03/19/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/28/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/15/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2024
ATRV
ATTORNEY REVIEW COMPLETED
10/31/2023
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
10/30/2023
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
09/16/2023
RFNT
REFUSAL PROCESSED BY IB
08/01/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/13/2023
RFRR
REFUSAL PROCESSED BY MPU
07/13/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/06/2023
CNRT
NON-FINAL ACTION WRITTEN
06/05/2023
DOCK
ASSIGNED TO EXAMINER
05/27/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/25/2023
MAFR
APPLICATION FILING RECEIPT MAILED
03/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/27/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/23/2023
Continuous trademark protection
Get notified about every new filing that threatens MAMMATYPER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.